Kidney Cancer Association

The Kidney Cancer Association (KCA), a charitable organization made up of patients, family members, physicians, researchers, and other health professionals from around the world. It is the world’s first international charity dedicated specifically to the eradication of death and suffering from renal cancers. It is also by far the largest kidney cancer charity, with members in more than 100 countries. They fund, promote, and collaborate with the National Cancer Institute (NCI), American Society for Clinical Oncology (ASCO), American Urological Association (AUA), and other institutions on research projects. They also educate families and physicians, and serve as an advocate on behalf of patients at the state and federal levels in the United States and globally. KCA was founded in 1990 by a small group of patients, including Eugene P. Schonfeld, Ph.D., and medical doctors in Chicago, Illinois. It is a nonprofit charity incorporated in the State of Illinois. It has also been designated as a tax exempt organization under Section 501(c)(3) of the U.S. Internal Revenue Service code. Donations to the Association are tax deductible. Our federal taxpayer identification number is 36-3719712. The Association conducts business under various state registered identities. They encourage both private and public sector institutions to do more research on kidney cancer.They help researchers in academic medical centers, government, and industry with money and information. They provide financial grants for basic research into the biology of kidney cancer. KCA members work to raise funds. These competitive awards are made from a pool of funds named in honor of the Association’s late founder, Eugene P. Schonfeld, Ph.D.KCA funds early-career cancer researchers through its Young Investigator Award (YIA) that provides funding to promising investigators to encourage and promote quality research in urology and clinical oncology. The purpose of this grant is to fund physicians and scientists during the transition from a fellowship program to a faculty appointment. Awards given are based on individual merit and availability of funds. They are represented in the membership of  the National Cancer Institute’s Renal Cancer Task Force, Biomarkers Consortium, Kidney Cancer SPORE, Cancer Leadership Council, Friends of Cancer Research, and many more collaborations, including our participation in The Cancer Genome Atlas.